Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine development
Pharma
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Following an activist investor feud earlier this year, vaccine developer Dynavax Technologies has agreed to sell itself to France’s Sanofi.
Fraiser Kansteiner
Dec 29, 2025 10:24am
12 former FDA chiefs blast Prasad's vaccine policy shake-ups
Dec 4, 2025 10:36am
Moderna outlines 3-year business strategy in bid to break even
Nov 20, 2025 2:54pm
GSK adds Moderna's next-gen COVID shot to mRNA patent lawsuit
Sep 5, 2025 10:06am
FDA to take harder look at coadministration of certain vaccines
Sep 4, 2025 10:40am
University of Michigan seeks damages over AZ's FluMist sales
Aug 29, 2025 10:15am
